Email this article Delayed Results of Experimental Afobazole Therapy in Rats after Acute Myocardial Infarction
- Authors: Kryzhanovskii S.A.1, Tsorin I.B.1, Stolyaruk V.N.1, Ionova E.O.1, Vititnova M.B.1
-
Affiliations:
- V. V. Zakusov Research Institute of Pharmacology
- Issue: Vol 163, No 2 (2017)
- Pages: 180-183
- Section: General Pathology and Pathophysiology
- URL: https://journals.rcsi.science/0007-4888/article/view/238738
- DOI: https://doi.org/10.1007/s10517-017-3761-7
- ID: 238738
Cite item
Open Access
Access granted
Subscription Access
Abstract
Delayed cardioprotective effects of anxiolytic Afobazole (15 mg/kg, intraperitoneally for 14 days) were evaluated using dynamic echocardiographic recordings on days 2, 15, 56, and 98 after experimental myocardial infarction modeling (rat model of acute myocardial ischemia). The cardiotropic activity of Afobazole is assumed to be related to its agonistic effects on σ1 receptor of cardiomyocytes. It was found that animals treated with Afobazole had no signs of heart failure by the end of observation, as evidenced by left ventricular ejection fraction.
About the authors
S. A. Kryzhanovskii
V. V. Zakusov Research Institute of Pharmacology
Author for correspondence.
Email: SAK_538@yandex.ru
Russian Federation, Moscow
I. B. Tsorin
V. V. Zakusov Research Institute of Pharmacology
Email: SAK_538@yandex.ru
Russian Federation, Moscow
V. N. Stolyaruk
V. V. Zakusov Research Institute of Pharmacology
Email: SAK_538@yandex.ru
Russian Federation, Moscow
E. O. Ionova
V. V. Zakusov Research Institute of Pharmacology
Email: SAK_538@yandex.ru
Russian Federation, Moscow
M. B. Vititnova
V. V. Zakusov Research Institute of Pharmacology
Email: SAK_538@yandex.ru
Russian Federation, Moscow
Supplementary files
